ECLERX.NS(ECLERX.NS)
ECLERX.NS
No analyst ratings available
No analyst price targets available for ECLERX.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $49.04B | $55.26B | $61.59B | $59.94B |
| Low | $47.11B | $50.86B | $61.58B | $56.30B |
| High | $51.26B | $57.47B | $61.61B | $62.49B |
| EBITDA Avg | $14.19B | $15.99B | $17.83B | $17.35B |
| Low | $13.64B | $14.72B | $17.82B | $16.30B |
| High | $14.84B | $16.63B | $17.83B | $18.09B |
| EBIT Avg | $12.05B | $13.58B | $15.14B | $14.73B |
| Low | $11.58B | $12.50B | $15.13B | $13.84B |
| High | $12.60B | $14.12B | $15.14B | $15.36B |
| Net Income Avg | $7.93B | $9.11B | $10.23B | $11.53B |
| Low | $7.72B | $8.86B | $9.65B | $10.62B |
| High | $8.67B | $10.05B | $11.35B | $12.17B |
| EPS Avg | $87.11 | $100.95 | $110.44 | $121.50 |
| Low | $81.39 | $93.35 | $101.64 | $111.92 |
| High | $91.37 | $105.89 | $119.56 | $128.22 |
| Analysts (Rev / EPS) | 9 / 9 | 9 / 9 | 5 / 5 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $11.90B | $12.42B | $12.84B |
| Low | $11.90B | $12.42B | $12.84B |
| High | $11.90B | $12.42B | $12.84B |
| EBITDA Avg | $3.44B | $3.60B | $3.72B |
| Low | $3.44B | $3.60B | $3.72B |
| High | $3.44B | $3.60B | $3.72B |
| EBIT Avg | $2.92B | $3.05B | $3.16B |
| Low | $2.92B | $3.05B | $3.16B |
| High | $2.92B | $3.05B | $3.16B |
| Net Income Avg | $1.86B | $2.07B | $2.23B |
| Low | $1.86B | $2.07B | $2.23B |
| High | $1.86B | $2.07B | $2.23B |
| EPS Avg | $19.70 | $21.90 | $23.60 |
| Low | $19.70 | $21.90 | $23.60 |
| High | $19.70 | $21.90 | $23.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |